About Tango Therapeutics
Tango Therapeutics is a company based in Cambridge (United States) founded in 2017.. Tango Therapeutics has raised $165 million across 5 funding rounds from investors including Gilead, Casdin Capital and Boxer Capital. The company has 155 employees as of December 31, 2024. Tango Therapeutics offers products and services including PRMT5 Program and CoREST Program. Tango Therapeutics operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Metabolon and MiRagen, among others.
- Headquarter Cambridge, United States
- Employees 155 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Tango Therapeutics, Inc.
-
Annual Revenue
$42.07 M15.17as on Dec 31, 2024
-
Net Profit
$-130.3 M-28.07as on Dec 31, 2024
-
EBITDA
$-143.1 M-28.04as on Dec 31, 2024
-
Total Equity Funding
$165 M (USD)
in 5 rounds
-
Latest Funding Round
$15 M (USD), Post-IPO
Oct 24, 2025
-
Investors
Gilead
& 4 more
-
Employee Count
155
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Tango Therapeutics
Tango Therapeutics is a publicly listed company on the NASDAQ with ticker symbol TNGX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Tango Therapeutics
Tango Therapeutics offers a comprehensive portfolio of products and services, including PRMT5 Program and CoREST Program. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Targets tumors using synthetic lethality for precision medicine.
Develops targeted therapies for cancer treatment approaches.
Unlock access to complete
Unlock access to complete
Leadership Team
43 people
Senior Team
9 people
Product Management Team
7 people
Software Development Team
6 people
Scientist Team
6 people
Scientific Team
5 people
Finance and Accounting
4 people
Human Resources and Administration
4 people
Unlock access to complete
Funding Insights of Tango Therapeutics
Tango Therapeutics has successfully raised a total of $165M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $15 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Post-IPO — $15.0M
-
First Round
First Round
(30 Mar 2017)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2025 | Amount | Post-IPO - Tango Therapeutics | Valuation |
investors |
|
| Aug, 2023 | Amount | Post-IPO - Tango Therapeutics | Valuation |
investors |
|
| Aug, 2020 | Amount | Series B - Tango Therapeutics | Valuation | Casdin Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Tango Therapeutics
Tango Therapeutics has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Gilead, Casdin Capital and Boxer Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Founded Year | Domain | Location | |
|
Biotech startups are funded by this venture capital firm.
|
Founded Year | Domain | Location | |
|
Tavistock Group is engaged in global diversified investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Tango Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Tango Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Tango Therapeutics Comparisons
Competitors of Tango Therapeutics
Tango Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Metabolon and MiRagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Solutions for biomarker discovery and diagnostic testing are provided.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Tango Therapeutics
Frequently Asked Questions about Tango Therapeutics
When was Tango Therapeutics founded?
Tango Therapeutics was founded in 2017.
Where is Tango Therapeutics located?
Tango Therapeutics is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Who is the current CEO of Tango Therapeutics?
Barbara Weber is the current CEO of Tango Therapeutics.
Is Tango Therapeutics a funded company?
Tango Therapeutics is a funded company, having raised a total of $165M across 5 funding rounds to date. The company's 1st funding round was a Series B of $50M, raised on Mar 30, 2017.
How many employees does Tango Therapeutics have?
As of Dec 31, 2024, the latest employee count at Tango Therapeutics is 155.
What is the annual revenue of Tango Therapeutics?
Annual revenue of Tango Therapeutics is $42.07M as on Dec 31, 2024.
What does Tango Therapeutics do?
Tango Therapeutics was founded in 2017 in Cambridge, United States, as a biotechnology firm focused on oncology. Precision therapies are created by identifying genetic vulnerabilities in tumor suppressor genes through DNA sequencing and CRISPR-based functional screens. Targets are selected for specific patient subgroups, exploiting synthetic lethality to induce tumor cell death while sparing healthy cells. Operations center on early-stage drug discovery in the precision medicine sector.
Who are the top competitors of Tango Therapeutics?
Tango Therapeutics's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
What products or services does Tango Therapeutics offer?
Tango Therapeutics offers PRMT5 Program and CoREST Program.
Is Tango Therapeutics publicly traded?
Yes, Tango Therapeutics is publicly traded on NASDAQ under the ticker symbol TNGX.
Who are Tango Therapeutics's investors?
Tango Therapeutics has 5 investors. Key investors include Gilead, Casdin Capital, Boxer Capital, Tavistock Group, and Third Rock Ventures.
What is Tango Therapeutics's ticker symbol?
The ticker symbol of Tango Therapeutics is TNGX on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.